- Home
- SRXH vs COEP Comparison
SRXH vs COEP Comparison
Compare SRXH & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRXH
- COEP
- Stock Information
- Founded
- SRXH 2013
- COEP 2017
- Country
- SRXH Canada
- COEP United States
- Employees
- SRXH N/A
- COEP N/A
- Industry
- SRXH
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRXH
- COEP Health Care
- Exchange
- SRXH NYSE
- COEP Nasdaq
- Market Cap
- SRXH 7.4M
- COEP 27.4M
- IPO Year
- SRXH N/A
- COEP N/A
- Fundamental
- Price
- SRXH $0.55
- COEP $9.47
- Analyst Decision
- SRXH
- COEP
- Analyst Count
- SRXH 0
- COEP 0
- Target Price
- SRXH N/A
- COEP N/A
- AVG Volume (30 Days)
- SRXH 577.4K
- COEP 38.0K
- Earning Date
- SRXH 05-15-2025
- COEP 08-15-2025
- Dividend Yield
- SRXH N/A
- COEP N/A
- EPS Growth
- SRXH N/A
- COEP N/A
- EPS
- SRXH N/A
- COEP N/A
- Revenue
- SRXH $119,421,918.00
- COEP $62,874.00
- Revenue This Year
- SRXH $26.28
- COEP N/A
- Revenue Next Year
- SRXH $25.00
- COEP N/A
- P/E Ratio
- SRXH N/A
- COEP N/A
- Revenue Growth
- SRXH 26.27
- COEP N/A
- 52 Week Low
- SRXH $0.47
- COEP $2.31
- 52 Week High
- SRXH $4.25
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- SRXH N/A
- COEP 62.24
- Support Level
- SRXH N/A
- COEP $7.25
- Resistance Level
- SRXH N/A
- COEP $9.90
- Average True Range (ATR)
- SRXH 0.00
- COEP 0.63
- MACD
- SRXH 0.00
- COEP 0.26
- Stochastic Oscillator
- SRXH 0.00
- COEP 85.62
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.